Experimental treatment shows promise in treating rare form of blindness

Dutch drugmaker ProQR Therapeutics has reported promising results from an early stage trial targeting children with a rare form of blindness.
Source: PharmaManufacturing.com - Category: Pharmaceuticals Source Type: news